Person: SEYİTHANOĞLU, MEHMET HAKAN
6 results
Search Results
Now showing 1 - 6 of 6
Publication Metadata only Comparison of TOF MRA, Contrast-Enhanced MRA and Subtracted CTA from CTP in Residue Evaluation of Treated Intracranial Aneurysms(2018-01-01) Dundar, TOLGA TURAN; Kits, Serkan; Ozdemir, HÜSEYİN; Seyithanoglu, MEHMET HAKAN; Uysal, Omer; Toprak, HÜSEYİN; Ozek, ERDİNÇ; Alkan, ALPAY; DÜNDAR, TOLGA TURAN; ARALAŞMAK, AYŞE; ÖZDEMİR, HÜSEYIN; SEYİTHANOĞLU, MEHMET HAKAN; UYSAL, ÖMER; TOPRAK, HÜSEYİN; KİTİŞ, SERKAN; ÖZEK, ERDİNÇ; ALKAN, ALPAYAIM: To compare effectiveness of contrast-enhanced magnetic resonance angiography (CE-MRA), 3D-Time-of-flight magnetic resonance angiography (3D-TOF-MRA) and subtracted computed tomography angiography from computed tomography perfusion (sub-CTA) in residue evaluation of intracranial aneurysms treated either with coiling or clipping.Publication Metadata only The efficacy of gamma knife radiosurgery in patients with trigeminal neuralgia: The initial experience of the Bezmialem Vakif University(2019-03-01T00:00:00Z) Akdag, Halil; Comert, Didem; Akdur, Kerime; Sakarcan, Ayten; Seyithanoglu, Hakan; HATİBOĞLU, MUSTAFA AZİZ; SEYİTHANOĞLU, MEHMET HAKAN; HATİBOĞLU, MUSTAFA AZİZBackground: Gamma knife stereotactic radiosurgery is, compared with surgical treatment, a less invasive treatment option for patients with trigeminal neuralgia (TN).Publication Metadata only Otogenic and rhinosinusogenic intracranial complications in children.(2017-12-05) TÜREL Ö.; USTABAŞ KAHRAMAN F.; DÜNDAR T. T.; SEYİTHANOĞLU M. H.; ÇAKIN Z. E.; DOĞAN DEMİR A.; TÜREL, ÖZDEN; USTABAŞ KAHRAMAN, FEYZA; DÜNDAR, TOLGA TURAN; SEYİTHANOĞLU, MEHMET HAKAN; DOĞAN DEMİR, AYŞEGÜLPublication Metadata only Choosing the most efficacious scoring method for carpal tunnel syndrome(2015-01-01T00:00:00Z) Yucel, Hulya; Seyithanoglu, Hakan; YÜCEL, HÜLYA; SEYİTHANOĞLU, MEHMET HAKANObjective: The aim of this study was to determine the most efficacious hand-specific questionnaire to determine functionality in patients with carpal tunnel syndrome.Publication Metadata only Effect of Short-term 900 MHz low level electromagnetic radiation exposure on blood serotonin and glutamate levels(2015-01-01T00:00:00Z) Eris, A. H.; Kiziltan, H. S.; Meral, I; Gene, H.; Trabzon, M.; Seyithanoglu, H.; Yagci, B.; Uysal, O.; MERAL, İSMAİL; SEYİTHANOĞLU, MEHMET HAKANBackground: Long term exposure to low level electromagnetic radiation (LLER) by using cellular phones causes serious health problems.Publication Metadata only Promising outcome of patients with recurrent glioblastoma after Gamma Knife-based hypofractionated radiotherapy(2024-03-01) HATİBOĞLU M. A.; Akdur K.; Sakarcan A.; SEYİTHANOĞLU M. H.; TÜRK H. M.; Sinclair G.; ÖZTANIR M. N.; HATİBOĞLU, MUSTAFA AZİZ; SEYİTHANOĞLU, MEHMET HAKAN; TÜRK, HACI MEHMET; ÖZTANIR, MUSTAFA NAMIKBackground: The role of Gamma Knife radiosurgery (GKRS) in recurrent glioblastoma remains unclear. The purpose of this study is to evaluate the effects of GKRS in a group of patients with recurrent glioblastoma, focusing on survival and safety. Methods: Patients undergoing GKRS for recurrent glioblastoma between September 2014 and April 2019 were included in this study. Relevant clinical and radiosurgical data, including GKRS-related complications, were recorded and analyzed. Overall survival (OS), local progression free survival (LPFS) and prognostic factors for outcome were thoroughly evaluated. Results: Fifty-three patients were analyzed (24 female, 29 male). The median age was 50 years (range, 19–78 years). The median GKRS treatment volume was 35.01 cm3 (range, 2.38-115.57 cm3). Twenty patients (38%) were treated with single fraction GKRS, while 33 (62%) were treated with GKRS-based hypofractionated stereotactic radiotherapy (HSRT). The median prescription dose for single fraction GKRS, 3-fractions HSRT and 5-fractions HSRT were 16 Gy (range, 10−20 Gy), 27 Gy (range, 18−33 Gy) and 25 Gy (range, 25−30 Gy), respectively. The median LPFS and OS times were 8.1 months and 11.4 months after GKRS, respectively. HSRT and Bevacizumab were associated with improved LPFS, while HSRT alone was associated with longer OS. Conclusion: Our findings suggested that HRST would likely improve LPFS and OS in definite settings; the addition of Bevacizumab to GKRS was associated with increased rates of local control. No major complications were reported. Further prospective studies are warranted to confirm our findings.